N02.4
Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Recurrent and persistent hematuria, characterized by the repeated presence of blood in the urine, can be a sign of a serious underlying kidney condition known as diffuse endocapillary proliferative glomerulonephritis. This condition involves inflammation and proliferation of cells within the tiny filtering units of the kidneys called glomeruli. Recognizing this condition is vital for early diagnosis and management, as it can impact kidney function over time.
Causes & Symptoms
Clinical Causes: Immune system disorders, such as post-infectious glomerulonephritis Vasculitis affecting small blood vessels in kidneys Lupus erythematosus causing lupus nephritis Certain infections that trigger immune responses in the kidneys Idiopathic causes where no specific cause is identified
Key Symptoms: Blood in the urine, often appearing smoky or cola-colored Swelling in the face, hands, feet, or abdomen due to fluid retention High blood pressure Urine that appears foamy or frothy Fatigue and weakness due to anemia or kidney impairment Decreased urine output in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical exam, and laboratory tests. The key steps include: - Urinalysis to detect blood and protein in the urine - Blood tests to assess kidney function and look for signs of inflammation - Imaging studies, such as ultrasound, to visualize kidney size and structure - Kidney biopsy, to examine tissue samples microscopically for characteristic changes typical of diffuse endocapillary proliferative glomerulonephritis These assessments help confirm the presence of inflammation and cell proliferation within the glomeruli and rule out other potential causes of hematuria.
Treatment Protocols: Management of this condition focuses on controlling inflammation, addressing the underlying cause, and preventing kidney damage. Treatment options may include: - Immunosuppressive medications such as corticosteroids or other agents to reduce immune system activity - Blood pressure medications, especially angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), to protect kidney function - Diuretics to manage swelling and fluid buildup - Antibiotics if an infection is identified as a trigger - Regular monitoring of kidney function and urine analysis - Dialysis or kidney transplant in advanced cases where kidney failure occurs It's important to work closely with healthcare providers to develop an individualized treatment plan based on disease severity and overall health.
Clinical Advice & FAQs
Billing Guidance
Is N02.4 a billable ICD-10 code?
Yes, N02.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N02.4?
Clinical documentation must specify the nature of Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference